A citation-based method for searching scientific literature

Iris E Overwater, André B Rietman, Sabine E Mous, Karen Bindels-de Heus, Dimitris Rizopoulos, Leontine W Ten Hoopen, Thijs van der Vaart, Floor E Jansen, Ype Elgersma, Henriette A Moll, Marie-Claire Y de Wit. Neurology 2019
Times Cited: 30







List of co-cited articles
364 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders.
Darcy A Krueger, Anjali Sadhwani, Anna W Byars, Petrus J de Vries, David N Franz, Vicky H Whittemore, Rajna Filip-Dhima, Donna Murray, Kush Kapur, Mustafa Sahin. Ann Clin Transl Neurol 2017
53
56

Everolimus for epilepsy and autism spectrum disorder in tuberous sclerosis complex: EXIST-3 substudy in Japan.
Masashi Mizuguchi, Hiroko Ikeda, Kuriko Kagitani-Shimono, Harumi Yoshinaga, Yasuhiro Suzuki, Makoto Aoki, Masae Endo, Masataka Yonemura, Masaya Kubota. Brain Dev 2019
33
43

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.
Jacqueline A French, John A Lawson, Zuhal Yapici, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J de Vries, Dennis J Dlugos, Noah Berkowitz,[...]. Lancet 2016
302
40

Neurological and neuropsychiatric aspects of tuberous sclerosis complex.
Paolo Curatolo, Romina Moavero, Petrus J de Vries. Lancet Neurol 2015
273
40

Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice.
Peter T Tsai, Court Hull, YunXiang Chu, Emily Greene-Colozzi, Abbey R Sadowski, Jarrett M Leech, Jason Steinberg, Jacqueline N Crawley, Wade G Regehr, Mustafa Sahin. Nature 2012
483
33

Beneficial Effects of Everolimus on Autism and Attention-Deficit/Hyperactivity Disorder Symptoms in a Group of Patients with Tuberous Sclerosis Complex.
Ayse Kilincaslan, Burcu Ece Kok, Pinar Tekturk, Cengiz Yalcinkaya, Cigdem Ozkara, Zuhal Yapici. J Child Adolesc Psychopharmacol 2017
38
30

Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist.
Petrus J de Vries, Vicky H Whittemore, Loren Leclezio, Anna W Byars, David Dunn, Kevin C Ess, Dena Hook, Bryan H King, Mustafa Sahin, Anna Jansen. Pediatr Neurol 2015
128
26

The natural history of epilepsy in tuberous sclerosis complex.
Catherine J Chu-Shore, Philippe Major, Susana Camposano, David Muzykewicz, Elizabeth A Thiele. Epilepsia 2010
344
26

Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex.
Atsushi Sato, Shinya Kasai, Toshiyuki Kobayashi, Yukio Takamatsu, Okio Hino, Kazutaka Ikeda, Masashi Mizuguchi. Nat Commun 2012
121
26

Prevalence of tuberous sclerosis estimated by capture-recapture analysis.
F J O'Callaghan, A W Shiell, J P Osborne, C N Martyn. Lancet 1998
164
23

The tuberous sclerosis complex.
Peter B Crino, Katherine L Nathanson, Elizabeth Petri Henske. N Engl J Med 2006
23

The neurology of mTOR.
Jonathan O Lipton, Mustafa Sahin. Neuron 2014
364
23

Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study.
Afshin Saffari, Ines Brösse, Adelheid Wiemer-Kruel, Bernd Wilken, Paula Kreuzaler, Andreas Hahn, Matthias K Bernhard, Cornelis M van Tilburg, Georg F Hoffmann, Matthias Gorenflo,[...]. Orphanet J Rare Dis 2019
44
23

Sirolimus for epilepsy in children with tuberous sclerosis complex: A randomized controlled trial.
Iris E Overwater, André B Rietman, Karen Bindels-de Heus, Caspar W N Looman, Dimitris Rizopoulos, Tafadzwa M Sibindi, Perumpillichira J Cherian, Floor E Jansen, Henriëtte A Moll, Ype Elgersma,[...]. Neurology 2016
42
20


TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study.
Petrus J de Vries, Elena Belousova, Mirjana P Benedik, Tom Carter, Vincent Cottin, Paolo Curatolo, Maria Dahlin, Lisa D'Amato, Guillaume B d'Augères, José C Ferreira,[...]. Orphanet J Rare Dis 2018
46
20

mTOR Signaling in Growth, Metabolism, and Disease.
Robert A Saxton, David M Sabatini. Cell 2017
20

Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis.
Dan Ehninger, Sangyeul Han, Carrie Shilyansky, Yu Zhou, Weidong Li, David J Kwiatkowski, Vijaya Ramesh, Alcino J Silva. Nat Med 2008
581
20

Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2.
Sohail F Tavazoie, Veronica A Alvarez, Dennis A Ridenour, David J Kwiatkowski, Bernardo L Sabatini. Nat Neurosci 2005
351
20

Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex.
A L Numis, P Major, M A Montenegro, D A Muzykewicz, M B Pulsifer, E A Thiele. Neurology 2011
114
20

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.
David Neal Franz, Elena Belousova, Steven Sparagana, E Martina Bebin, Michael Frost, Rachel Kuperman, Olaf Witt, Michael H Kohrman, J Robert Flamini, Joyce Y Wu,[...]. Lancet 2013
486
20

Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study.
Rima Nabbout, Elena Belousova, Mirjana P Benedik, Tom Carter, Vincent Cottin, Paolo Curatolo, Maria Dahlin, Lisa D Amato, Guillaume Beaure d'Augères, Petrus J de Vries,[...]. Epilepsia Open 2018
53
20

Influence of seizures on early development in tuberous sclerosis complex.
Jamie K Capal, Beatriz Bernardino-Cuesta, Paul S Horn, Donna Murray, Anna Weber Byars, Nicole M Bing, Bridget Kent, Deborah A Pearson, Mustafa Sahin, Darcy A Krueger. Epilepsy Behav 2017
80
16


Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex.
Sergiusz Jóźwiak, Katarzyna Kotulska, Dorota Domańska-Pakieła, Barbara Lojszczyk, Małgorzata Syczewska, Dariusz Chmielewski, Dorota Dunin-Wąsowicz, Tomasz Kmieć, Joanna Szymkiewicz-Dangel, Maria Kornacka,[...]. Eur J Paediatr Neurol 2011
182
16

Mutations causing syndromic autism define an axis of synaptic pathophysiology.
Benjamin D Auerbach, Emily K Osterweil, Mark F Bear. Nature 2011
413
16

Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis.
Helen S Bateup, Caroline A Johnson, Cassandra L Denefrio, Jessica L Saulnier, Karl Kornacker, Bernardo L Sabatini. Neuron 2013
205
16

Sensitive Periods for Cerebellar-Mediated Autistic-like Behaviors.
Peter T Tsai, Stephanie Rudolph, Chong Guo, Jacob Ellegood, Jennifer M Gibson, Samantha M Schaeffer, Jazmin Mogavero, Jason P Lerch, Wade Regehr, Mustafa Sahin. Cell Rep 2018
35
16


Cognitive impairment in tuberous sclerosis complex is a multifactorial condition.
F E Jansen, K L Vincken, A Algra, P Anbeek, O Braams, M Nellist, B A Zonnenberg, A Jennekens-Schinkel, A van den Ouweland, D Halley,[...]. Neurology 2008
129
16

Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study.
Romina Moavero, Arianna Benvenuto, Leonardo Emberti Gialloreti, Martina Siracusano, Katarzyna Kotulska, Bernhard Weschke, Kate Riney, Floor E Jansen, Martha Feucht, Pavel Krsek,[...]. J Clin Med 2019
28
17

Abnormal mTOR Activation in Autism.
Kellen D Winden, Darius Ebrahimi-Fakhari, Mustafa Sahin. Annu Rev Neurosci 2018
75
16

Preventive Antiepileptic Treatment in Tuberous Sclerosis Complex: A Long-Term, Prospective Trial.
Sergiusz Jozwiak, Monika Słowińska, Julita Borkowska, Krzysztof Sadowski, Barbara Łojszczyk, Dorota Domańska-Pakieła, Dariusz Chmielewski, Magdalena Kaczorowska-Frontczak, Jagoda Głowacka, Kamil Sijko,[...]. Pediatr Neurol 2019
31
16

Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism.
F Kyle Satterstrom, Jack A Kosmicki, Jiebiao Wang, Michael S Breen, Silvia De Rubeis, Joon-Yong An, Minshi Peng, Ryan Collins, Jakob Grove, Lambertus Klei,[...]. Cell 2020
419
16

Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis.
Raffaella Cusmai, Romina Moavero, Roberta Bombardieri, Federico Vigevano, Paolo Curatolo. Epilepsy Behav 2011
82
13

Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex Infants.
Joyce Y Wu, Jurriaan M Peters, Monisha Goyal, Darcy Krueger, Mustafa Sahin, Hope Northrup, Kit Sing Au, Gary Cutter, E Martina Bebin. Pediatr Neurol 2016
66
13

mTOR complexes in neurodevelopmental and neuropsychiatric disorders.
Mauro Costa-Mattioli, Lisa M Monteggia. Nat Neurosci 2013
204
13

The genomic landscape of tuberous sclerosis complex.
Katie R Martin, Wanding Zhou, Megan J Bowman, Juliann Shih, Kit Sing Au, Kristin E Dittenhafer-Reed, Kellie A Sisson, Julie Koeman, Daniel J Weisenberger, Sandra L Cottingham,[...]. Nat Commun 2017
90
13

Tuberous sclerosis complex.
Elizabeth P Henske, Sergiusz Jóźwiak, J Christopher Kingswood, Julian R Sampson, Elizabeth A Thiele. Nat Rev Dis Primers 2016
222
13

Neuron-Glia Interactions Increase Neuronal Phenotypes in Tuberous Sclerosis Complex Patient iPSC-Derived Models.
Aishwarya G Nadadhur, Mouhamed Alsaqati, Lisa Gasparotto, Paulien Cornelissen-Steijger, Eline van Hugte, Stephanie Dooves, Adrian J Harwood, Vivi M Heine. Stem Cell Reports 2019
37
13

Genetically engineered human cortical spheroid models of tuberous sclerosis.
John D Blair, Dirk Hockemeyer, Helen S Bateup. Nat Med 2018
74
13

Characterization of autism in young children with tuberous sclerosis complex.
Shafali S Jeste, Mustafa Sahin, Patrick Bolton, George B Ploubidis, Ayla Humphrey. J Child Neurol 2008
123
13

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.
John J Bissler, J Christopher Kingswood, Elżbieta Radzikowska, Bernard A Zonnenberg, Michael Frost, Elena Belousova, Matthias Sauter, Norio Nonomura, Susanne Brakemeier, Petrus J de Vries,[...]. Lancet 2013
491
13

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.
M van Slegtenhorst, R de Hoogt, C Hermans, M Nellist, B Janssen, S Verhoef, D Lindhout, A van den Ouweland, D Halley, J Young,[...]. Science 1997
13

Molecular neurobiology of mTOR.
Katarzyna Switon, Katarzyna Kotulska, Aleksandra Janusz-Kaminska, Justyna Zmorzynska, Jacek Jaworski. Neuroscience 2017
162
13

Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.
Lynsey Meikle, Kristen Pollizzi, Anna Egnor, Ioannis Kramvis, Heidi Lane, Mustafa Sahin, David J Kwiatkowski. J Neurosci 2008
347
13

The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex.
Sharon W Way, Natalia S Rozas, Henry C Wu, James McKenna, R Michelle Reith, S Shahrukh Hashmi, Pramod K Dash, Michael J Gambello. Hum Mol Genet 2012
60
13

Developmental brain abnormalities in tuberous sclerosis complex: a comparative tissue analysis of cortical tubers and perituberal cortex.
Véronique Ruppe, Pelin Dilsiz, Carol Shoshkes Reiss, Chad Carlson, Orrin Devinsky, David Zagzag, Howard L Weiner, Delia M Talos. Epilepsia 2014
63
13

Disruption of mTOR and MAPK pathways correlates with severity in idiopathic autism.
Eleonora Rosina, Barbara Battan, Martina Siracusano, Lorena Di Criscio, Fiona Hollis, Laura Pacini, Paolo Curatolo, Claudia Bagni. Transl Psychiatry 2019
39
13

mTOR inhibitor reverses autistic-like social deficit behaviours in adult rats with both Tsc2 haploinsufficiency and developmental status epilepticus.
Miriam Schneider, Petrus J de Vries, Kai Schönig, Veit Rößner, Robert Waltereit. Eur Arch Psychiatry Clin Neurosci 2017
21
19


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.